Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR‐mutated lung cancer-Reference-Cited by-同舟云学术

Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR‐mutated lung cancer

Published:2018-11-08 Issue:3 Volume:144 Page:545-557
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Treue Denise¹^ORCID,Bockmayr Michael¹²,Stenzinger Albrecht³⁴⁵^ORCID,Heim Daniel¹,Hester Svenja⁶,Klauschen Frederick¹⁴⁵

Affiliation:

1. Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität BerlinHumboldt‐Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology Berlin Germany

2. Department of Pediatric Hematology and OncologyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

3. University of Heidelberg, Institute of Pathology Heidelberg Germany

4. German Cancer Consortium (DKTK) Germany

5. German Cancer Research Center (DKFZ) Heidelberg Germany

6. Department of BiochemistryUniversity of Oxford Oxford United Kingdom

Funder

Einstein Stiftung Berlin

Human Frontier Science Program

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31845

Reference38 articles.

1. Accumulation of driver and passenger mutations during tumor progression

2. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance

3. Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer: Fig. 1.

4. Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

5. Mutational heterogeneity in cancer and the search for new cancer-associated genes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation;Cancers;2024-03-21

2. Single-cell gene regulatory network prediction by explainable AI;Nucleic Acids Research;2023-01-11

3. EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools;Journal of Biomolecular Structure and Dynamics;2022-12-16

4. Patient-level proteomic network prediction by explainable artificial intelligence;npj Precision Oncology;2022-06-07

5. Comprehensive micro-scaled proteome and phosphoproteome characterization of archived retrospective cancer repositories;Nature Communications;2021-06-11